These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 35233377)
1. A Novel Prognostic Biomarker LPAR6 in Hepatocellular Carcinoma via Associating with Immune Infiltrates. He J; Meng M; Wang H J Clin Transl Hepatol; 2022 Feb; 10(1):90-103. PubMed ID: 35233377 [TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidic Acid Receptor 6 (LPAR6) Is a Potential Biomarker Associated with Lung Adenocarcinoma. He J; Gao R; Meng M; Yu M; Liu C; Li J; Song Y; Wang H Int J Environ Res Public Health; 2021 Oct; 18(21):. PubMed ID: 34769557 [TBL] [Abstract][Full Text] [Related]
3. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers. Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L Front Immunol; 2019; 10():6. PubMed ID: 30761122 [No Abstract] [Full Text] [Related]
4. Lysophosphatidic acid receptor 6 regulated by miR-27a-3p attenuates tumor proliferation in breast cancer. Lei J; Guo S; Li K; Tian J; Zong B; Ai T; Peng Y; Zhang Y; Liu S Clin Transl Oncol; 2022 Mar; 24(3):503-516. PubMed ID: 34510318 [TBL] [Abstract][Full Text] [Related]
5. MARCKS on Tumor-Associated Macrophages is Correlated with Immune Infiltrates and Poor Prognosis in Hepatocellular Carcinoma. Ren X; Ju Y; Wang C; Wei R; Sun H; Zhang Q Cancer Invest; 2021 Oct; 39(9):756-768. PubMed ID: 34279157 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of CISD1 Predicts Worse Survival in Hepatocarcinoma Patients. Lu T; Li C; Xiang C; Gong Y; Peng W; Chen C Biomed Res Int; 2022; 2022():7823191. PubMed ID: 35313629 [TBL] [Abstract][Full Text] [Related]
7. BRCA1-Associated Protein Is a Potential Prognostic Biomarker and Is Correlated With Immune Infiltration in Liver Hepatocellular Carcinoma: A Pan-Cancer Analysis. Ju Q; Li XM; Zhang H; Zhao YJ Front Mol Biosci; 2020; 7():573619. PubMed ID: 33240929 [TBL] [Abstract][Full Text] [Related]
8. DCK is a promising prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma. Song D; Wang Y; Zhu K; Tian L; Gao Q; Zhou J; Fan J; Wang X World J Surg Oncol; 2020 Jul; 18(1):176. PubMed ID: 32690026 [TBL] [Abstract][Full Text] [Related]
9. CDCA3 Is a Novel Prognostic Biomarker Associated with Immune Infiltration in Hepatocellular Carcinoma. Wang Z; Chen S; Wang G; Li S; Qin X Biomed Res Int; 2021; 2021():6622437. PubMed ID: 33604380 [TBL] [Abstract][Full Text] [Related]
10. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma. Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633 [TBL] [Abstract][Full Text] [Related]
11. Xanthine dehydrogenase as a prognostic biomarker related to tumor immunology in hepatocellular carcinoma. Lin Z; Xie YZ; Zhao MC; Hou PP; Tang J; Chen GL Cancer Cell Int; 2021 Sep; 21(1):475. PubMed ID: 34496841 [TBL] [Abstract][Full Text] [Related]
12. AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma. Ma C; Kang W; Yu L; Yang Z; Ding T Front Oncol; 2020; 10():590006. PubMed ID: 33363020 [TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidic Acid Receptor 6 (LPAR6) Expression and Prospective Signaling Pathway Analysis in Breast Cancer. Tao K; Guo S; Chen R; Yang C; Jian L; Yu H; Liu S Mol Diagn Ther; 2019 Feb; 23(1):127-138. PubMed ID: 30694446 [TBL] [Abstract][Full Text] [Related]
14. Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma. Zhu ZY; Tang N; Wang MF; Zhou JC; Wang JL; Ren HZ; Shi XL Front Immunol; 2021; 12():781087. PubMed ID: 35069553 [TBL] [Abstract][Full Text] [Related]
15. NEFM DNA methylation correlates with immune infiltration and survival in breast cancer. Li D; Zhao W; Zhang X; Lv H; Li C; Sun L Clin Epigenetics; 2021 May; 13(1):112. PubMed ID: 34001208 [TBL] [Abstract][Full Text] [Related]
16. A distinctive protein signature induced by lysophosphatidic acid receptor 6 (LPAR6) expression in hepatocellular carcinoma cells. Lippolis R; Gnocchi D; Santacroce L; Siciliano RA; Mazzeo MF; Scacco S; SabbĂ C; Mazzocca A Biochem Biophys Res Commun; 2020 Jun; 526(4):1150-1156. PubMed ID: 32321639 [TBL] [Abstract][Full Text] [Related]
17. Correlation Between Prognostic Biomarker Zhao J; Yang Z; Tu M; Meng W; Gao H; Li MD; Li L Front Oncol; 2021; 11():608641. PubMed ID: 34367941 [TBL] [Abstract][Full Text] [Related]
18. A comprehensive analysis of the diagnostic and prognostic value associated with the Yan L; He J; Liao X; Liang T; Zhu J; Wei W; He Y; Zhou X; Peng T Gland Surg; 2022 Feb; 11(2):389-411. PubMed ID: 35284318 [TBL] [Abstract][Full Text] [Related]
19. SLC13A4 Might Serve as a Prognostic Biomarker and be Correlated with Immune Infiltration into Head and Neck Squamous Cell Carcinoma. Yang ML; Zhang JH; Li S; Zhu R; Wang L Pathol Oncol Res; 2021; 27():1609967. PubMed ID: 34840533 [TBL] [Abstract][Full Text] [Related]
20. Correlation analysis of RDM1 gene with immune infiltration and clinical prognosis of hepatocellular carcinoma. Qiu C; Li Z; Cao W; Cai X; Ye L; Zhang C; Ma Y; Wang X; Yang Y Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34435618 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]